SCHEMBL4530998

SCHEMBL4530998

COc1ccc(Cn2cnc3c(NCCc4cc5cccc(Cl)c5c(C(=O)O)n4)ncnc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HTT P42858 2/20 0.46
HDAC2 Q92769 1/20 0.44
AURKA O14965 1/20 0.43
RPS6KB1 P23443 1/20 0.43
HPGD P15428 1/20 0.43
TMIGD3 P0DMS9 2/20 0.42
ADORA2A P29274 2/20 0.42
ADORA1 P30542 2/20 0.42
ADORA2B P29275 1/20 0.42
MAPT P10636 2/20 0.42
CTSL P07711 2/20 0.41
NR3C1 P04150 2/20 0.41
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
FGFR1 P11362 1/20 0.41
FGFR2 P21802 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4542188 0.91 HDAC1 (0.43) HDAC1HDAC6HTTHDAC2AURKA
SCHEMBL4533401 0.90 HDAC1 (0.46) HDAC1HDAC6HTTHDAC2HPGD
SCHEMBL4542862 0.88 HTT (0.45) HDAC1HDAC6HTTHPGDTMIGD3
SCHEMBL4534986 0.87 HDAC1 (0.44) HDAC1HDAC6HTTHDAC2HPGD
SCHEMBL4539184 0.85 HDAC1 (0.43) HDAC1HDAC6HTTHDAC2HPGD
SCHEMBL4539338 0.85 CTSL (0.47) HDAC1HDAC6HTTHPGDTMIGD3
SCHEMBL3706244 0.83 HDAC1 (0.47) HDAC1HDAC6HTTHPGDMAPT
SCHEMBL3706237 0.83 HDAC1 (0.47) HDAC1HDAC6HTTHPGDMAPT
SCHEMBL4541032 0.83 MAPT (0.47) HDAC1HDAC6HTTHPGDTMIGD3
SCHEMBL4564684 0.82 HDAC1 (0.42) HDAC1HDAC6HTTHPGDTMIGD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637669-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2013-09-18 EP disclosed
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed